These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1682290)
1. Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients. Schlosberg A; Barr F Isr J Psychiatry Relat Sci; 1991; 28(2):60-3. PubMed ID: 1682290 [TBL] [Abstract][Full Text] [Related]
2. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo. Balant LP; Balant-Gorgia AE; Eisele R; Reith B; Gex-Fabry M; Garrone G Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763 [TBL] [Abstract][Full Text] [Related]
3. Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial. Matar AM; Abdel-Mawgoud M; Skov S J Clin Psychopharmacol; 1990 Aug; 10(4):283-6. PubMed ID: 1981068 [TBL] [Abstract][Full Text] [Related]
4. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses. Amdisen A; Nielsen MS; Dencker SJ; Fensbo C; Ahlfors UG; Gravem A; Baastrup PC; Bjerkenstedt L; Gunby B; Wiesel FA Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816 [TBL] [Abstract][Full Text] [Related]
5. Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients. Chakravarti SK; Muthu A; Muthu PK; Naik P; Pinto RT Curr Med Res Opin; 1990; 12(1):58-65. PubMed ID: 1971560 [TBL] [Abstract][Full Text] [Related]
6. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics. Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979 [TBL] [Abstract][Full Text] [Related]
7. A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis. Baastrup PC; Alhfors UG; Bjerkenstedt L; Dencker SJ; Fensbo C; Gravem A; Pedersen V; Elgen K; Brekke B; Fredslund-Andersen K Acta Psychiatr Scand; 1993 Jan; 87(1):48-58. PubMed ID: 8093824 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study. Tan CH; Low BL; Ng LL; Khoo YM; Lee HS Ther Drug Monit; 1993 Apr; 15(2):108-12. PubMed ID: 8099240 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study]. Romain JL; Dermain P; Greslé P; Grignon S; Moisan P; Nore D; Pech G; Benyaya J; Perret I Encephale; 1996; 22(4):280-6. PubMed ID: 9035983 [TBL] [Abstract][Full Text] [Related]
10. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129 [TBL] [Abstract][Full Text] [Related]
11. Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo. Amdisen A; Aaes-Jørgensen T; Thomsen NJ; Madsen VT; Nielsen MS Psychopharmacology (Berl); 1986; 90(3):412-6. PubMed ID: 2878462 [TBL] [Abstract][Full Text] [Related]
13. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G; Safadi G; Beauclair L J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017 [TBL] [Abstract][Full Text] [Related]
14. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness. Mann BS; Moslehuddin KS; Owen RT; Clayton AR; Rohatgi KK; Sud P; Vaddadi KS Pharmatherapeutica; 1985; 4(6):387-92. PubMed ID: 2867559 [TBL] [Abstract][Full Text] [Related]
15. Acute psychotic disorders treated with 5% zuclopenthixol acetate in 'Viscoleo' ('Cisordinol-Acutard'), a global assessment of the clinical effect: an open multi-centre study. Løwert AC; Rasmussen EM; Holm R; Almbjerg F; Calberg H; Joensen A; Nimb M; Baden H; Andersen E; Westergård T Pharmatherapeutica; 1989; 5(6):380-6. PubMed ID: 2687895 [TBL] [Abstract][Full Text] [Related]
16. The use of oral zuclopenthixol in the treatment of functional psychotic illness. Bereen FJ; Harte FB; Maguire J; Singh AN Pharmatherapeutica; 1987; 5(1):62-8. PubMed ID: 3602024 [TBL] [Abstract][Full Text] [Related]
17. An open study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses. Fend I; Jochum W; Eberhardt G; König P Schizophr Res; 1988; 1(5):359-61. PubMed ID: 2908705 [No Abstract] [Full Text] [Related]
18. Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients. Taymeeyapradit U; Kuasirikul S J Med Assoc Thai; 2002 Dec; 85(12):1301-8. PubMed ID: 12678168 [TBL] [Abstract][Full Text] [Related]
19. [Zuclopenthixol acetate and haloperidol in acute psychoses. Results of the AMDP subgroup in a multicenter Belgian study]. Bourdouxhe S; Mirel J; Denys W; Bobon D Acta Psychiatr Belg; 1987; 87(2):236-44. PubMed ID: 3618274 [TBL] [Abstract][Full Text] [Related]
20. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales. Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]